Drug Trial Radar · NCT01070615
Study to Evaluate Long-Term Tolerability and Safety of Oral Prucalopride in Chronic Constipation
Last checked: Nov 20, 2026Latest source record: Mar 2, 2010 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
693
Actual
Start
Jun 1998
Primary completion
Nov 2000
Sponsor
- Lead sponsor
- MovetisIndustry
- Sponsor type
- Industry
- First posted
- Feb 18, 2010
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Objectives: Evaluation of the clinical long-term safety, tolerability, patient satisfaction, pharmacokinetics and pattern of use of oral prucalopride tablets given in doses up to 4 mg once daily to patients with chronic constipation
Conditions
- Chronic Constipation
Interventions
PrucaloprideDrug
Primary outcomes
What the sponsor says the trial is designed to measure.
No primary outcomes listed.
Locations
1 site in 1 country. Site status is shown where the registry gives one.
University Hospital Antwerp
Edegem, Belgium
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.